{"id":"W2149654081","doi":"10.1016/s1470-2045(14)70472-3","title":"Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; University of Ottawa; Jewish General Hospital; Regional Municipality of Durham; Princess Margaret Cancer Centre; BC Cancer Agency; Queen's University; Juravinski Cancer Centre","funders":"Cancer Care Ontario; Cancer Research Institute","keywords":"Medicine; Internal medicine; Erlotinib; Gefitinib; Placebo; Lung cancer; Population; Performance status; Oncology; Cancer; Adverse effect; Clinical trial; Surgery; Epidermal growth factor receptor; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004064155,0.0003243377,0.001239949,0.000126681,0.0001260211,0.00002323632,0.0001934104,0.00008343421,0.0001957441],"category_scores_gemma":[0.00004465953,0.0001606285,0.00006475082,0.000402344,0.0001412586,0.00008595685,0.00003051044,0.0003188545,0.00001238635],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004641504,"about_ca_system_score_gemma":0.0009101187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003798645,"about_ca_topic_score_gemma":0.002591095,"domain_scores_codex":[0.9980379,0.0003031315,0.0004559949,0.0004197973,0.0002517287,0.0005314721],"domain_scores_gemma":[0.998246,0.000586128,0.0003636096,0.0004747957,0.0001744708,0.0001550093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9790225,0.002427663,0.01111838,0.0001693527,0.0007219064,0.00006273805,0.001864783,0.0008916793,0.00006739775,0.00001438542,0.000722556,0.002916659],"study_design_scores_gemma":[0.9813638,0.008394375,0.002267301,0.0002584462,0.002108727,0.00001691105,0.0002322016,0.001737246,0.0002669911,0.000006758544,0.003117467,0.0002298215],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840155,0.0001614998,0.0004501979,0.00114628,0.0002289803,0.008974734,0.00005992971,0.00008597804,0.004876908],"genre_scores_gemma":[0.9921492,0.00006737306,0.001784307,0.0008938534,0.0002565414,0.003746466,0.0001991481,0.00006526415,0.0008378451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008851077,"threshold_uncertainty_score":0.6550239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04442332365077933,"score_gpt":0.3947671100906369,"score_spread":0.3503437864398576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}